1.63

7.39% -0.13

Pre-market: 1.62 -0.010 -0.61%

Hookipa Pharma Inc (HOOK)

Overview News Price History Option Chain Financials Discussions Forecast

Hookipa Pharma Inc stock is traded at $1.63, with a volume of 154.67K. It is down -7.39% in the last 24 hours and down -24.88% over the past month. HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Previous Close:

$1.76

Open:

$1.72

24h Volume:

154.67K

Relative Volume:

1.28

Market Cap:

$19.65M

Revenue:

$52.16M

Net Income/Loss:

$-48.60M

P/E Ratio:

-0.3773

EPS:

-4.32

Net Cash Flow:

$-77.48M

1W Performance:

-13.30%

1M Performance:

-24.88%

6M Performance:

-69.36%

1Y Performance:

-74.54%

1-Day Range:

$1.5508

$1.81

1-Week Range:

$1.5508

$1.91

52-Week Range:

$1.5508

$10.50

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name

Hookipa Pharma Inc

Sector

Healthcare (1167)

Industry

Biotechnology (674)

Phone

0114318906360

Address

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY

Employee

124

Twitter

@HookipaPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

HOOK's Discussions on Twitter

Compare HOOK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOOK Hookipa Pharma Inc	1.63	19.65M	52.16M	-48.60M	-77.48M	-4.32
VRTX Vertex Pharmaceuticals Inc	480.35	123.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	723.47	79.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	624.94	37.97B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.20	31.74B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	259.70	27.71B	3.32B	-860.46M	-1.04B	-8.32

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-15-24	Reiterated	RBC Capital Mkts	Outperform
Dec-02-22	Downgrade	BofA Securities	Buy → Underperform
Nov-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-08-21	Initiated	Morgan Stanley	Overweight
Nov-03-20	Initiated	Truist	Buy
Oct-26-20	Initiated	JMP Securities	Mkt Outperform
Oct-19-20	Resumed	H.C. Wainwright	Buy
Sep-27-19	Initiated	H.C. Wainwright	Buy
May-13-19	Initiated	BofA/Merrill	Buy
May-13-19	Initiated	RBC Capital Mkts	Outperform

View All

Hookipa Pharma Inc Stock (HOOK) Latest News

Feb 25, 2025

Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India

Feb 25, 2025

Feb 23, 2025

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN

Feb 23, 2025

Feb 21, 2025

BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter

Feb 21, 2025

HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia

Feb 21, 2025

Poolbeg slumps as Hookipa merger is called off - pharmaphorum

Feb 21, 2025

Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World

Feb 21, 2025

Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk

Feb 21, 2025

Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors USA

Feb 21, 2025

Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView

Feb 21, 2025